| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| BeiGene, Ltd. | Director | Ordinary Shares | 46K | $9.55M | $207.72 | Jun 5, 2024 | Direct |
| Century Therapeutics, Inc. | Director | Stock Option (right to buy) | 44K | Jun 20, 2024 | Direct | ||
| BeiGene, Ltd. | Director | Share Option (Right to Buy) | 34.2K | Jun 5, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| IPSC | Century Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
| BGNE | BeiGene, Ltd. | Jun 5, 2024 | 2 | $0 | 4 | Jun 7, 2024 | Director |
| IPSC | Century Therapeutics, Inc. | Jun 27, 2023 | 1 | $0 | 4 | Jun 29, 2023 | Director |
| BGNE | BeiGene, Ltd. | Jun 15, 2023 | 2 | $0 | 4 | Jun 20, 2023 | Director |
| BGNE | BeiGene, Ltd. | Jun 22, 2022 | 2 | $0 | 4 | Jun 24, 2022 | Director |
| IPSC | Century Therapeutics, Inc. | Jun 9, 2022 | 1 | $0 | 4 | Jun 10, 2022 | Director |
| BGNE | BeiGene, Ltd. | Feb 28, 2022 | 1 | $0 | 4 | Mar 2, 2022 | Director |
| BGNE | BeiGene, Ltd. | Feb 1, 2022 | 0 | $0 | 3 | Feb 7, 2022 | Director |
| IPSC | Century Therapeutics, Inc. | Jun 17, 2021 | 1 | $0 | 4 | Jun 21, 2021 | Director |
| IPSC | Century Therapeutics, Inc. | Jun 17, 2021 | 0 | $0 | 3 | Jun 17, 2021 | Director |